Plain-English translation of NCT06387654 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is building a large collection of biological samples—such as blood and skin tissue—from people with autoimmune, immune-related, or inflammatory skin diseases. Researchers will study these samples to better understand what causes these conditions and to identify patterns that could help doctors diagnose and treat patients more effectively in the future.
Many immune-related skin diseases are rare and poorly understood, and doctors still struggle to diagnose them early and choose the best treatment for each individual patient. By collecting and studying biological samples from a large group of patients, researchers hope to uncover the underlying causes of these diseases and develop better, more personalized approaches to care.
You likely qualify if…
You likely don't qualify if…
As a participant, you would have biological samples collected as part of your normal diagnosis and follow-up care at the hospital—no extra visits would be needed. The researchers will take samples like blood or skin tissue that are already being gathered for your medical care, and use them to study your condition more deeply. There is no set duration; participation is ongoing as long as you continue receiving care for your skin condition.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
France
Sponsor
University Hospital, Toulouse
Enrollment target
~800 participants
Started
May 2024
Primary completion
April 2029
Age range
6 Years – 99 Years
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Chloé BOST, MD, PhD
University Hospital, Toulouse
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.